Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,914.00
Bid: 10,918.00
Ask: 10,922.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.037%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 10,914.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks dip on surging virus cases, stimulus doubts

Mon, 26th Oct 2020 13:22

* Unease over record virus cases in Europe, U.S.

* German DAX hits three-month low as SAP slumps

* Investors seek dollar safety

* Italy bond yields slide after S&P move

* Eyes this week on central bank meetings, U.S. GDP data

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

By Tom Arnold and Wayne Cole

LONDON/SYDNEY, Oct 26 (Reuters) - Global shares fell on
Monday as surging coronavirus cases in Europe and the United
States clouded the global economic outlook, while China's
leaders meet to plan the country's economic future.

The United States has seen its highest-ever number of new
COVID-19 cases in the past two days. France also set case
records and Spain announced a state of emergency.

The coronavirus resurgence, along with no clear progress on
a U.S. stimulus package and caution before the Nov. 3 U.S.
election, dragged the MSCI world equity index
down 0.3%. In Europe, the Euro STOXX 600 shed 1%. S&P
500 futures fell 1%.

"The decreasing likelihood of U.S. fiscal stimulus
pre-election, possibly even pre-year-end, as well as worsening
virus numbers and increasing lockdown measures, all seem to be
taking the shine off what was a rather complacent market view of
the outlook," said James Athey, investment director at Aberdeen
Standard Investments.

Europe became the second region after Latin America to
surpass 250,000 deaths on Saturday, according to a Reuters
tally, as many European countries reported their highest number
of COVID-19 cases in a single day.

Milan's blue-chip index sank 1% as new curbs on
public venues overshadowed Friday's news that ratings agency S&P
Global had upgraded the nation's sovereign outlook to stable
from negative.

The German DAX slumped 2.7% to a three-month low
after software company SAP abandoned medium-term
profitability targets and warned its business would take longer
than expected to recover from the pandemic.

Sentiment was also hit by a survey showing German business
morale fell for the first time in six months in October.

Reports of progress in a COVID-19 vaccine being developed by
the University of Oxford and manufactured by drug maker
AstraZeneca Plc helped limit some of the market
sell-off, analysts said.

MSCI's broadest index of Asia-Pacific shares outside Japan
shed 0.2%. Japan's Nikkei finished 1%
lower, and South Korea's main index lost 0.7%.

Chinese blue chips shed 0.6% as the country's
leaders met to chart the nation's economic course for 2021-2025,
balancing growth with reforms amid an uncertain global outlook
and worsening relations with the United States.

In a packed week for monetary policy decisions, Canada's and
Japan's central banks are expected to hold fire for now. Markets
assume the European Central Bank will sound cautious on
inflation and growth even if it skips a further easing.

Data due out Thursday is forecast to show a consumer-led
31.9% rebound in U.S. economic output in the third quarter,
after the second quarter's historic collapse.

Analysts at Westpac noted such a bounce would still leave
2020 GDP around 4% below last year's, with business investment
still lagging badly.

As markets increasingly price in the likelihood of a
Democratic president and Congress and resulting rise in
government spending and borrowing, U.S. 10-year Treasury yields
hit their highest since early June last week at 0.8720%
. They were trading at 0.81% on Monday.

"We have raised the probability of a Democratic sweep,
already our base case, from 40% to just over 50% and have
increased our expectation of Biden to win from 65% to 75%,"
NatWest Markets analysts said. "We see steeper U.S. yield curves
and a weaker USD as likely to prevail in our base case."

Italian government bond yields slid across the curve, with
short-dated yields falling to a one-year low, after S&P Global's
unexpected outlook upgrade.

The benchmark 10-year yield dropped 6 basis points to 0.70%
. Short-dated two-year Italian yields hit
their lowest level in a year at -0.382%.

Surging coronavirus cases sent investors to the safety of
the dollar after it fell broadly last week.

An index tracking its value against a basket of currencies
firmed 0.1% to 92.92, while euro/dollar - the most traded
currency pair and part of the index - fell 0.3% to 1.1826
.

In commodity markets, gold was 0.1% higher at
$1,902.06 per ounce.

Oil prices extended last week's losses as the prospect of
increased supply and resurgent coronavirus infections worried
investors.

Brent crude was down 1.9% at $40.97 a barrel. U.S.
West Texas Intermediate (WTI) dropped 2.1% to $39.03.

(Reporting by Tom Arnold in London and Wayne Cole in Sydney;
editing by Shri Navaratnam, Tomasz Janowski, Larry King)

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.